Table 1 Motility of pancreatic cancer cells
From: RHOA and PRKCZ control different aspects of cell motility in pancreatic cancer metastatic clones
Primary tumors | Sex | Age | Diagnosis | Motility (μm/min) |
|---|---|---|---|---|
PT-1 | M | 59 | PDAC | 0,3 |
PT-2 | M | 70 | PDAC | 1 ± 0,2 |
PT-3 | M | 61 | PDAC | 0,4 ± 0,1 |
PT-4 | M | 54 | PDAC | 0,8 ± 0,2 |
PT-5 | F | 66 | PDAC | 0,8 ± 0,2 |
PT-6 | F | 76 | PDAC | 1,5 ± 0,1 |
PT-7 | F | 69 | PDAC | 0 |
PT-8 | M | 68 | PDAC | 0 |
PT-9 | M | 70 | ACT | 0 |
PT-10 | F | 63 | IPMT | 0 |
PT-11 | F | 61 | PET | 0 |
PT-12 | F | 42 | PET | 0 |
Cell lines | ||||
MCC1 | / | / | MCT-CR | 0 |
AVC1 | / | / | AVC | 0,1 |
SK-PC1 | / | / | PDAC | 2 ± 0,3 |
S2-m | / | / | PDAC | 3.3 ± 0.8 |
S2-CP9 | / | / | PDAC | 4 ± 2 |